17 Apr 2026
Abstract LB031: Transcriptomic evaluation of a potent s-trifluoromethyl phenyl acetamide derivative for its anticancer effectPublisher siteCancer Research, Protein Degradation and Inhibitors
UniversitiesEman A. Fayed
Active, last published 2026
In synthesis and biological activity
Eman A.
Fayed
Scholar“Research focused on Synthesis and biological activity and adjacent fields.”
Al-Azhar University
Claim Your Profile30
H-index
2.0k
Citations
Eman has not officially claimed their profile. If you are Eman, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
man A. Fayed is a researcher working on Synthesis and biological activity. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Eman's work has been cited 1,960 times across 3 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Synthesis and biological activity×38Synthesis and Biological Evaluation×20Click Chemistry and Applications×11Cancer therapeutics and mechanisms×10Synthesis and Characterization of Heterocyclic Compounds×9
04 · Where I am
Affiliations
Affiliation on published researchAl-Azhar UniversityDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
8 works3 Apr 2026
Abstract 996: Novel sulfonamide-aromatic amine hybrids: Synthesis, cytotoxic screening, and transcriptomic insights into anticancer activityPublisher siteCancer Research, Enzyme function and inhibition
2 Jan 2026Open access2cites
From bench to brain: novel thieno-oxazine hybrids as potent pleiotropic anti-Alzheimer’s agents with <i>in vivo</i> / <i>in vitro</i> validation and <i>in silico</i> insightsPublisher siteJournal of Enzyme Inhibition and Medicinal Chemistry, Synthesis and biological activity
1 Jan 2026Open access
A structural blueprint for antibacterial discovery: microwave- and ultrasound-assisted synthesis of pyrrolidine-fused quinoxalines as novel inhibitors of DNA gyrase and biofilmPublisher siteRSC Advances, Synthesis and Biological Evaluation
3 Oct 2025Open access6cites
Flufenamic acid-based sulfonohydrazide and acetamide derivatives NSAI as inhibitors of multi-targets COX-1/COX-2/5-LOX: design, synthesis, in silico ADMET and binding mode studiesPublisher siteBMC Chemistry, Synthesis and biological activity
17 Aug 2025Open access6cites
Unlocking Therapeutic Potential of Novel Thieno-Oxazepine Hybrids as Multi-Target Inhibitors of AChE/BChE and Evaluation Against Alzheimer’s Disease: In Vivo, In Vitro, Histopathological, and Docking StudiesPublisher sitePharmaceuticals, Cholinesterase and Neurodegenerative Diseases
27 Jan 20258cites
Novel Pyrrolidine-bearing quinoxaline inhibitors of DNA Gyrase, RNA polymerase and spike glycoproteinPublisher siteBioorganic Chemistry, Synthesis and Biological Evaluation
2 Dec 202420cites
Exploring a novel thiazole derivatives hybrid with fluorinated-indenoquinoxaline as dual inhibitors targeting VEGFR2/AKT and apoptosis inducers against hepatocellular carcinoma with docking simulationPublisher siteBioorganic Chemistry, Synthesis and biological activity
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Eman?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you